The reports addressed today offer information from three very technical studies dealing with:
- Genomic profiling of localized prostate cancers among African American men
- “DNA licensing” and prostate cancer progression
- Interleukin-6 over-expression and bicalutamide resistance … READ MORE …
Filed under: Diagnosis, Drugs in development, Prevention, Risk | Tagged: African American, bicalutamide, DNA licensing, genomic profile, interleukin-6 | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 